Multiple Myeloma

Multiple Myeloma

A Phase 2 Single Arm Study of Elotuzumab in Combination with Pomalidomide and Low Dose Dexamethasone (EPd) in Patients with Multiple Myeloma Relapsed or Refractory to Prior Treatment with Lenalidomide – Bristol Myers Squibb – CA204142